| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 53 |
| 1 | TACROLIMUS | 3 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 3 | TACROLIMUS OINTMENT 0.1% | 3 |
| 4 | ACETAMINOPHEN | 2 |
| 5 | CETIRIZINE HYDROCHLORIDE | 2 |
| 6 | LEBRIKIZUMAB-LBKZ | 2 |
| 7 | LIFITEGRAST | 2 |
| 8 | OMEPRAZOLE | 2 |
| 9 | OMEPRAZOLE MAGNESIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEBRIKIZUMAB-LBKZ | 2 | 0.0009 |
| 1 | TIMOLOL MALEATE OPHTHALMIC | 2 | 0.0003 |
| 2 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 1 | 0.0002 |
| 3 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | TIMOLOL MALEATE | 2 | 0.0002 |
| 5 | CLONIDINE HYDROCHLORIDE | 1 | 0.0002 |
| 6 | TRALOKINUMAB-LDRM | 1 | 0.0001 |
| 7 | LIFITEGRAST | 2 | 0.0001 |
| 8 | DUPILUMAB | 53 | 0.0001 |
| 9 | NEMOLIZUMAB-ILTO | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-13 Antagonist [EPC] | 3 | 0.0004 |
| 1 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 53 | 0.0001 |
| 3 | Interleukin-31 Receptor alpha Antagonist [EPC] | 1 | 0.0001 |
| 4 | Catecholamine [EPC] | 1 | 0.0000 |
| 5 | Anti-IgE [EPC] | 1 | 0.0000 |
| 6 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 9 | Estrogen [EPC] | 1 | 0.0000 |